Clinical Trial Update: Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of clofarabine and cyclophosphamide in patients with relapsed or refractory acute leukemia, chronic myeloid leukemia, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Clofarabine (Clolar) (clofarabine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: COMPLETED